Angioedema News and Research

RSS
Angioedema is the rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa and submucosal tissues. It is very similar to urticaria, but urticaria, commonly known as hives, occurs in the upper dermis.
Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Santarus launches UCERIS for induction of remission in patients with ulcerative colitis

Dyax fourth quarter total revenues increase to $16.0 million

Dyax fourth quarter total revenues increase to $16.0 million

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

FDA approves Santarus’ UCERIS for induction of remission in patients with ulcerative colitis

FDA approves Santarus’ UCERIS for induction of remission in patients with ulcerative colitis

AMAG seeks FDA sNDA approval for Feraheme Injection

AMAG seeks FDA sNDA approval for Feraheme Injection

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

New data from AstraZeneca's FASLODEX studies on breast cancer to be presented at SABSC

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

Top-line results from Pfizer's pregabalin CR formulation Phase 3 study on fibromyalgia

General guidelines to understand allergic skin conditions

General guidelines to understand allergic skin conditions

Leading allergy organizations release report that sheds light on angioedema

Leading allergy organizations release report that sheds light on angioedema

BioCryst completes planned interim analysis of peramivir Phase 3 trial for serious influenza

BioCryst completes planned interim analysis of peramivir Phase 3 trial for serious influenza

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

FDA accepts Sunovion’s two LATUDA sNDAs for review

FDA accepts Sunovion’s two LATUDA sNDAs for review

BioRx added to Zemaira distribution network

BioRx added to Zemaira distribution network

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

FDA extends PDUFA target action date for review of Santarus' UCERIS NDA

FDA extends PDUFA target action date for review of Santarus' UCERIS NDA